Cartesian Therapeutics, Inc. (RNAC)
8.05
-0.29
(-3.48%)
USD |
NASDAQ |
May 07, 12:01
Cartesian Therapeutics SG&A Expense (TTM) : 30.27M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Precision BioSciences, Inc. | 23.69M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |